Navigation Links
Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

OXFORD, England, Nov. 30 /PRNewswire/ -- Chroma Therapeutics Limited announced today that it will report efficacy data from a Phase I clinical trial of its oral, once-daily experimental cancer therapy CHR-2797 at the forthcoming American Society of Hematology (ASH) meeting. CHR-2797 is the only oral aminopeptidase inhibitor currently in clinical development. The company will also be presenting the results of various preclinical studies. Details of the presentations are as follows:

Abstract # 443: oral presentation

Title: A Phase I Study of CHR-2797, an Orally Active Aminopeptidase

Inhibitor in Elderly and/or Treatment Refractory Patients with Acute

Myeloid Leukemia

Location and timing: Acute Myeloid Leukemias: Therapy, excluding

Transplantation-Novel Therapies, Rooms A411-A412: Monday December 10,

2007, 13:30-15:00 Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

Abstract # 1608, Poster # 762

Title: Cellular Aminopeptidase Inhibition as a Target for the Therapy of

AML by the Novel Agent CHR-2797

Location and timing: Poster Session I, Hall B4: Saturday, December 8,

2007, 17:30-19:30 Eastern Standard Time

Presenter: Dr Chris Jenkins (University Hospital, Cardiff, UK)

Abstract # 2505, Poster # 695

Title: Aminopeptidase Inhibition as a Targeted Treatment Strategy in


Location and timing: Poster Session II, Hall B4: Sunday, December 9,

2007, 18:00-20:00, Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

The ASH posters will be available at the company's website, following the above presentations.


Chroma Therapeutics Limited

Ian Nicholson Chief Executive Officer +44 (0)1235 829120'/>"/>

SOURCE Chroma Therapeutics Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Amada Senior ... opened its newest office in Maryland – its Bethesda location. Amada ... as a project management technology consultant to many of the largest construction firms ...
(Date:10/9/2015)... ... October 09, 2015 , ... BrightStar Care® of ... Cabarrus County Active Living and Parks for its outstanding commitment to volunteering with ... to consistently going above and beyond the call of duty, seniors on the ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dignity Health named Dr. David C. Morro ... – Chandler–McQueen opening later this month. The new facility is licensed under ... West Valley. , “Dr. Morro is an excellent leader and will ensure our ...
(Date:10/9/2015)... ... 2015 , ... When the producers of the popular ‘Ask This Old House’ ... Hollywood, CA, they turned to a trusted resource in Tamarack Technologies. , “Our HV ... because of our successful past experience with the show they enlisted our help,” said ...
(Date:10/9/2015)... ... , ... Bag Tags Inc. will provide custom bag tags, ... the annual IRONMAN World Championship in Kailua-Kona, Hawaii, this Saturday, October 10. ... place in Hawaii every year since 1978. , As part of its ongoing ...
Breaking Medicine News(10 mins):
... , LOS ANGELES, Oct. 9 Torrid,s 2009 House of ... for the retailer known as the destination for young women,s ... the courtyard at the Fashion Institute of Design and Merchandising ... who work to motivate women and to support the National ...
... cancer epidemic, researchers say , FRIDAY, Oct. 9 (HealthDay News) ... increase in cases of a rare type of head and ... -- a tumor that grows behind the nose and at ... about one of every 100,000 people in the United States. ...
... of Hematology (ASH) is proud to announce the ... which builds hematologic capacity in developing countries. Through ... countries receive valuable clinical, laboratory, or technological training ... under the mentorship of an ASH member anywhere ...
... ... as CMS-mandated Home Health Agency Satisfaction Reporting Set to Begin , , ... South Bend, IN (Vocus) October ... country, and a new report released today finds an upward trend in overall home ...
... fight treatment-related bone loss, researchers say , FRIDAY, Oct. 9 ... of vitamin D, which could lead to weaker bones and ... doses of vitamin D for them. , "Vitamin D is ... have accelerated bone loss due to the nature of hormone ...
... ... 19, 2009 in San Diego, CA., , ... Horsham, PA (Vocus) October 8, 2009 -- The Drug Information Association (DIA) ... 2009 in San Diego, CA., , , , ,Electronic CTD is poised to become the ...
Cached Medicine News:
(Date:10/9/2015)... , October 9, 2015 ... --> The report summarizes key ... overall status of the manufacturers making ... and direction for companies and individuals ... . --> ...
(Date:10/9/2015)... 9, 2015 Henry Schein , Inc. ... health care products and services to office-based dental, animal ... the Henry Schein Disaster Relief Hotline is open for ... financial issues as a result of the disastrous flooding ... number for all Henry Schein customers is ...
(Date:10/9/2015)... , Oct. 9, 2015   Lexicon Pharmaceuticals, Inc. ... TELESTAR Phase 3 clinical study of telotristat etiprate has been ... annual symposium to be held from October 15-17, in ... with patients who completed the randomized treatment portion of the ... a poster session. --> --> ...
Breaking Medicine Technology:
... WIRE)--Apr 26, 2007 - A new study ... of Child Neurology indicates,that a treatment from ... cerebral palsy improves their quality of life ... The findings of this Medtronic-sponsored study should,expand ...
... Effectiveness of Hypertension,Treatment Valsartan in Preventing Cardiovascular ... /Xinhua-PRNewswire/ -- The clinical,outcomes of the JIKEI ... the Jikei University School of Medicine, was ... The,Lancet. The study, involving more than 3,000 ...
Cached Medicine Technology:
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag....
Silicone Flat Hubless Drains...
Bard® Channel Drain...
Used to negotiate spiral folds of the cystic duct and the lumen of the common duct. TFE coating reduces surface tension. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: